OptiBiotix Health Plc (AIM: OPTI)
Health Care · Biotechnology · GB
£0.06
-4.24% today · -37.9% 1Y
OptiBiotix Health Plc (AIM: OPTI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $7.79M.
Over the last twelve months the share price has lost 37.9%, trading between 0.05 and 0.10.
Tweenvest scores OptiBiotix Health Plc across four factors: quality 45/100, value 32/100, growth 100/100. Its strongest factor is growth.
OPTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $7.79M
- Revenue (TTM)
- $1.71M
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 1.78
- 52-week high
- £0.10
- 52-week low
- £0.05
- Avg volume (3M)
- —
- Shares outstanding
- 103.30M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| NFL Biosciences SAENXTPA: ALNFL | $8.08M | €0.57 | -8.55% |
| Vivesto ABOM: VIVE | $8.06M | Skr7.21 | -3.74% |
| OSR Health, Inc.OTCPK: OSRH | $7.94M | $0.23 | +15.90% |
| Delta-Fly Pharma, Inc.TSE: 4598 | $7.86M | ¥84.00 | -15.15% |
| Bolt Biotherapeutics, Inc.NasdaqCM: BOLT | $7.71M | $4.00 | -2.68% |
| Soligenix, Inc.NasdaqCM: SNGX | $7.69M | $0.35 | -2.89% |
| Immuron LimitedASX: IMC | $7.64M | AU$0.03 | -24.44% |
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | $7.59M | $0.02 | -20.19% |
Figures last refreshed Oct 18, 2026.